Personalized Medicines In Oncology Market - Forecast(2019 - 2024)

Report Code: HCR 0097 Report Format: PDF + Excel (Delivery in 48 Hrs)

Oncology Market Overview:

According to the UK based Cancer Research Institute, cancer was responsible for around 9.6 million deaths in the world in 2018. Additionally, approximately 18 million cases of cancer were reported in the same year.[1] Detrimental lifestyle changes are responsible for the consistently rising number of cancer patients in the world, which in turn has generated a high demand for oncology. Oncology has been fundamental in prevention of cancer throughout the world.

 

The oncology market will witness remarkable growth in the upcoming years owing to the increase in disposable income, growth of the medical technology sector, and elevated demand for cancer treatment. During the forecast period 20192025, the market is estimated to grow at a burgeoning compound annual growth rate (CAGR) of 12.6%. In 2018, the  global oncology market was valued at $120 billion.

 

Oncology Market Outlook:

 

Oncology, to put simply, is the study of cancer its causes, symptoms, diagnosis, and treatment. Detection of cancer is not as difficult as it used to be because of oncology, and this branch aims to educate people about the potential dangers of this disease, and how as a society, humans can take small steps towards eradicating it. Home to the eminent Cancer Research Institute, a US-based non profitable organization, was the leader in terms of regional revenue generation, cultivating 46% of the global revenues. There are different kinds of oncology including medical oncology, which makes use of medicines or chemotherapy, a surgical oncology in which the surgeon removes the tumor from the tissue; and radiation oncology, which utilizes radiation therapy. The chemotherapy application segment is projected to expand at an outstanding CAGR of 13.6 % during the forecast period 20192025.

 

Oncology Market Growth Drivers:

 

Ø  Harmful Lifestyle Patterns Contributing to Global Prevalence of Cancer

 

According to National Center for Biotechnology Information (NCBI), majority of the diagnosed cancer cases can be related to harmful lifestyles that patients have led in the past. Sedentary lifestyle, unhealthy diet, and excessive tobacco usage are some of the leading causes of cancer. Such factors are contributing to the growth of the oncology market and resulting in developments in the field.

 

Ø  Government Initiatives for Cancer Prevention

 

Governments around the world are trying to fight cancer through several initiatives that they have begun for spreading awareness on cancer prevention. The Centers for Disease Control and Prevention in the U.S. has started some significant initiatives such as Screen for Life: National Colorectal Cancer Action Campaign for colorectal campaign, Inside Knowledge Campaign for gynecologic cancer, Youth Risk Behavior Surveillance System and National Health Interview Survey for skin cancer, and many others. These initiatives highly rely on the branch of oncology and use most of its findings and research, providing impetus to the oncology market and generating demand.

 

Oncology Market Challenges:

 

Cancer is an expensive disease and treatment is not accessible for people of all economic backgrounds. Because of limited information, in a lot of cases, cancer remains undetected. These are some of the challenges faced by the oncology market and can be combated only by creating inexpensive treatment methods for the general public.

 

Oncology Market Key Players Perspective:

 

Some of the key players of the oncology market are F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Novartis AG, Pfizer, Sanofi, Amgen Inc., Johnson & Johnson, AstraZeneca PLC, AbbVie Inc., Astellas Pharma Inc., and Exelixis, Inc.

 

Novartis AG, one the of world’s leading pharmaceutical companies, is researching extensively in oncology through its Novartis Institutes for BioMedical Research (NIBR) and introducing new forms of treatments, such as experimental gene therapy, in the market.

 

Oncology Market Trends:

 

With consistent technological advancement, the oncology market is experiencing immense innovation and making cancer diagnostics and treatment of cancer easier.

Ø  The iKnife  Researchers have developed a surgical instrument called the iKnife, which is a knife that can instantly figure out whether a particular set of cells is cancerous or not. When cutting through a tissue, the knife releases a specific type of smoke that is used for cancer detection.

Ø  Medical Robots  Doctors around the world are repeatedly handing over the incision part of a surgery to medical robots, thanks to automation. This segment of the surgery, which has a high chance of error, is carefully handed by these robots to offer tremor-free surgeries, thus resulting in high rates of successful surgery.

Ø  CAR T-Cell Therapy  While still in its budding stage, this form of immunotherapy is gaining immense popularity amongst patients suffering from leukemia. A patient’s blood is collected in this procedure and genetically modified by adding Chimeric Antigen Receptors (CARs) in the blood and left to expand. When the blood is sufficiently full of CARs, it is then transferred to the patient’s body. CARs present in the blood begin to attack the tumor cells, thus curing a patient’s cancer without the need for external procedures such as chemotherapy or radiation therapy.

 

Oncology Market Research Scope

 

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Oncology Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.

 

Oncology Market Report: Industry Coverage

 

The oncology market can be segmented on the basis of type and therapy type. On the basis of type, the market can be bifurcated into breast cancer, lung cancer, blood cancer, brain cancer, and others. On the basis of therapy type, the market can be divided into medical oncology, radiation oncology, and surgical oncology.

 

The oncology market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

 

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia


[1] https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf

1. Market Overview
2. Executive Summary
3. Personalized Medicines In Oncology Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Personalized Medicines In Oncology Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Personalized Medicines In Oncology Market
      4.3.1. Power of Suppliers
      4.3.2. Threats From New Entrants
      4.3.3. Power of Buyer
      4.3.4. Threat From Substitute Product
      4.3.5. Degree of Competition
5. Personalized Medicines In Oncology -Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
6. Personalized Medicines In Oncology- By Tumore Type
   6.1. Genomics
   6.2. Proteomics
   6.3. Metabolomics
   6.4. Epigenetics
7. Personalized Medicines In Oncology- By Service
   7.1. Molecular Oncopathology
   7.2. Genome Diagnostics
   7.3. Radiation Therapy
   7.4. Oncology Testing
   7.5. Chemotherapy
   7.6. Others
8. Personalized Medicines In Oncology- By Occurence
   8.1. Colorectal/ stomach/ esophageal
   8.2. Ovarian
   8.3. Lung
   8.4. Brest
   8.5. Sarcoma
   8.6. Pancreatic
   8.7. Cancer
   8.8. Mesothelioma
   8.9. Others
9. Personalized Medicines In Oncology- By Technology
   9.1. Next-Generation Sequencing
   9.2. Fluorescence/ Chromogenic In Situ Hybridization
   9.3. Immunohistochemistry
   9.4. Microarray
   9.5. Quantitative PCR
   9.6. High Throughput SNP Analysis
   9.7. Others
10. Personalized Medicines In Oncology- By End User
   10.1. Research Centers
   10.2. Governmental Institutions
   10.3. Hospitals
   10.4. others
11. Personalized Medicines In Oncology- Geography
   11.1.  Americas
      11.1.1. U.S.
      11.1.2. Canada
      11.1.3. Brazil
      11.1.4. Others
   11.2. Europe
      11.2.1. U.K.
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. France
      11.2.5. Others
   11.3. Asia Pacific
      11.3.1. China 
      11.3.2. Japan
      11.3.3. Australia & New Zealand
      11.3.4. Others
   11.4. Rest of The World (RoW)
      11.4.1. Middle East
      11.4.2. Africa
12. Personalized Medicines In Oncology Entropy
   12.1. New Product Developments
   12.2. Product Launches, JVs, Mergers and Acquisitions
13. Company Profiles
   13.1. Agendia Nv
   13.2. Allere Laboratory
   13.3. Alpha Genomix
   13.4. Ariana Pharma
   13.5. Biocrates
   13.6. Biodiscovery
   13.7. Biotheranostics
   13.8. Boreal Genomics, Inc.
   13.9. Caris Life Sciences
   13.10. Chordoma Foundation
   13.11. CompanionDx
   13.12. Cypher Genomics
   13.13. deCode Genetics
   13.14. Diploid
   13.15. DNA Link
   13.16. Edge Bio
   13.17. Foundation Medicine
   13.18. Fulgent Diagnostics
   13.19. Gene TLC
   13.20. GenebyGene
   13.21. Genomic Engenharia Molecular
   13.22. Genomic Health, Inc.
   13.23. Illumina, Inc. 
   13.24. Life Technologies Corporation
   13.25. MapMyGenome
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix

   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
List of Tables

Table 1: Personalized Medicines In Oncology Market Overview 2019-2024
Table 2: Personalized Medicines In Oncology Market Leader Analysis 2018-2019 (US$)
Table 3: Personalized Medicines In Oncology Market Product Analysis 2018-2019 (US$)
Table 4: Personalized Medicines In Oncology Market End User Analysis 2018-2019 (US$)
Table 5: Personalized Medicines In Oncology Market Patent Analysis 2013-2018* (US$)
Table 6: Personalized Medicines In Oncology Market Financial Analysis 2018-2019 (US$)
Table 7: Personalized Medicines In Oncology Market Driver Analysis 2018-2019 (US$)
Table 8: Personalized Medicines In Oncology Market Challenges Analysis 2018-2019 (US$)
Table 9: Personalized Medicines In Oncology Market Constraint Analysis 2018-2019 (US$)
Table 10: Personalized Medicines In Oncology Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Personalized Medicines In Oncology Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Personalized Medicines In Oncology Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Personalized Medicines In Oncology Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Personalized Medicines In Oncology Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Personalized Medicines In Oncology Market Value Chain Analysis 2018-2019 (US$)
Table 16: Personalized Medicines In Oncology Market Pricing Analysis 2019-2024 (US$)
Table 17: Personalized Medicines In Oncology Market Opportunities Analysis 2019-2024 (US$)
Table 18: Personalized Medicines In Oncology Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Personalized Medicines In Oncology Market Supplier Analysis 2018-2019 (US$)
Table 20: Personalized Medicines In Oncology Market Distributor Analysis 2018-2019 (US$)
Table 21: Personalized Medicines In Oncology Market Trend Analysis 2018-2019 (US$)
Table 22: Personalized Medicines In Oncology Market Size 2018 (US$)
Table 23: Personalized Medicines In Oncology Market Forecast Analysis 2019-2024 (US$)
Table 24: Personalized Medicines In Oncology Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 26: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Genomics, 2019-2024 ($)
Table 27: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Proteomics, 2019-2024 ($)
Table 28: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Metabolomics, 2019-2024 ($)
Table 29: Personalized Medicines In Oncology Market By Tumore Type, Revenue & Volume, By Epigenetics, 2019-2024 ($)
Table 30: Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 31: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Molecular Oncopathology, 2019-2024 ($)
Table 32: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Genome Diagnostics, 2019-2024 ($)
Table 33: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Radiation Therapy, 2019-2024 ($)
Table 34: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Oncology Testing, 2019-2024 ($)
Table 35: Personalized Medicines In Oncology Market By Service, Revenue & Volume, By Chemotherapy, 2019-2024 ($)
Table 36: Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 37: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Next-Generation Sequencing, 2019-2024 ($)
Table 38: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Fluorescence/ Chromogenic In Situ Hybridization, 2019-2024 ($)
Table 39: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Immunohistochemistry, 2019-2024 ($)
Table 40: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Microarray, 2019-2024 ($)
Table 41: Personalized Medicines In Oncology Market By Technology, Revenue & Volume, By Quantitative PCR, 2019-2024 ($)
Table 42: Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 43: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Colorectal/ stomach/ esophageal, 2019-2024 ($)
Table 44: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Ovarian, 2019-2024 ($)
Table 45: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Lung, 2019-2024 ($)
Table 46: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Brest, 2019-2024 ($)
Table 47: Personalized Medicines In Oncology Market By Occurrence, Revenue & Volume, By Sarcoma, 2019-2024 ($)
Table 48: Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 49: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Research Centers, 2019-2024 ($)
Table 50: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Governmental Institutions, 2019-2024 ($)
Table 51: Personalized Medicines In Oncology Market By End User, Revenue & Volume, By Hospitals, 2019-2024 ($)
Table 52: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 53: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 54: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 55: North America Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 56: North America Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 57: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 58: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 59: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 60: South america Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 61: South america Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 62: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 63: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 64: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 65: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 66: Europe Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 67: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 68: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 69: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 70: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 71: APAC Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 72: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 73: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 74: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 75: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 76: Middle East & Africa Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 77: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 78: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 79: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 80: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 81: Russia Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 82: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Tumore Type, 2019-2024 ($)
Table 83: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Service, 2019-2024 ($)
Table 84: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 85: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By Occurrence, 2019-2024 ($)
Table 86: Israel Personalized Medicines In Oncology Market, Revenue & Volume, By End User, 2019-2024 ($)
Table 87: Top Companies 2018 (US$)Personalized Medicines In Oncology Market, Revenue & Volume
Table 88: Product Launch 2018-2019Personalized Medicines In Oncology Market, Revenue & Volume
Table 89: Mergers & Acquistions 2018-2019Personalized Medicines In Oncology Market, Revenue & Volume


List of Figures

Figure 1: Overview of Personalized Medicines In Oncology Market 2019-2024
Figure 2: Market Share Analysis for Personalized Medicines In Oncology Market 2018 (US$)
Figure 3: Product Comparison in Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 4: End User Profile for Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Personalized Medicines In Oncology Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Personalized Medicines In Oncology Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Personalized Medicines In Oncology Market 2018-2019
Figure 8: Ecosystem Analysis in Personalized Medicines In Oncology Market 2018
Figure 9: Average Selling Price in Personalized Medicines In Oncology Market 2019-2024
Figure 10: Top Opportunites in Personalized Medicines In Oncology Market 2018-2019
Figure 11: Market Life Cycle Analysis in Personalized Medicines In Oncology Market
Figure 12: GlobalBy Tumore TypePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy ServicePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy TechnologyPersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy OccurrencePersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 16: GlobalBy End UserPersonalized Medicines In Oncology Market Revenue, 2019-2024 ($)
Figure 17: Global Personalized Medicines In Oncology Market - By Geography
Figure 18: Global Personalized Medicines In Oncology Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 19: Global Personalized Medicines In Oncology Market CAGR, By Geography, 2019-2024 (%)
Figure 20: North America Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 21: US Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 63: U.K Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 96: China Personalized Medicines In Oncology Market Value & Volume, 2019-2024
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($)Personalized Medicines In Oncology Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Personalized Medicines In Oncology Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 125: Russia Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Personalized Medicines In Oncology Market Value & Volume, 2019-2024 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%)Personalized Medicines In Oncology Market
Figure 134: Developments, 2018-2019*Personalized Medicines In Oncology Market
Figure 135: Company 1 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Personalized Medicines In Oncology Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Personalized Medicines In Oncology Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Personalized Medicines In Oncology Market Net Sales Share, By Geography, 2018 (%)